Brahms mid-segment anterior atrial natriuretic test set - Taiwan Registration cd10558e5ba0085168439918a640c18b
Access comprehensive regulatory information for Brahms mid-segment anterior atrial natriuretic test set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number cd10558e5ba0085168439918a640c18b and manufactured by B.R.A.H.M.S GmbH. The authorized representative in Taiwan is MEDTRI CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
Quantitatively detect mid-anteroatrial natriuretic peptide (MR-proANP) in human serum or plasma (containing EDTA or heparin) with B.R.A.H.M.S KRYPTOR/KRYPTOR compact/KRYPTOR Compact PLUS analyzer.
A Clinical chemistry and clinical toxicology
A.1117 B type B natriuretic peptide test system
import
Dates and Status
May 10, 2012
May 10, 2027